Table 2.

Mann-Whitney U test results of correlation between imaging features and BRCA mutation status.

Imaging features	BRCA
	BRCA wild type	BRCA mutation type	P value
Side			0.624
Left	14 (24.14%)	12 (32.43%)
Right	20 (34.48%)	9 (24.32%)
Both	24 (41.38%)	16 (43.25%)
Margins			0.089
Smooth	19 (32.76%)	5 (13.51%)
Irregular	39 (67.24%)	32 (86.49%)
Architecture			0.673
Cystic/predominantly cystic	22 (37.93%)	15 (40.54%)
Solid/predominantly solid	36 (62.07%)	22 (59.46%)
Calcification			0.568
Present	8 (13.79%)	6 (16.22%)
Absent (reference)	50 (86.21%)	31 (83.78%)
Ascites			0.167
None	13 (22.41%)	4 (10.81%)
Small	25 (43.10%)	15 (40.54%)
Large	20 (34.49%)	17 (48.65%)
Distant metastases
Liver metastasis			0.177
Present	12 (20.69%)	13 (35.14%)
Absent (reference)	46 (79.31%)	24 (64.86%)
Spleen metastasis			0.6673
Present	9 (15.52%)	7 (18.92%)
Absent (reference)	49 (84.48%)	30 (81.08%)
Gastrohepatic ligament			0.753
Present	14 (24.14%)	10 (27.03%)
Absent (reference)	44 (75.86%)	27 (72.97%)
Peritoneum
peritoneal metastasis	52 (89.66%)	29 (78.38%)	< 0.01
Nodular	14 (26.92%)	23 (79.31%)
Infiltrative	38 (73.08%)	6 (20.69%)
Absent (reference)	6 (10.34%)	8 (21.62%)
Mesentery			0.036
Present	10 (17.24%)	12 (32.43%)
Absent (reference)	48 (82.76%)	25 (67.57%)
Lymphadenopathy
Supradiaphragmatic			0.006
Present	10 (17.24%)	16 (43.24%)
Absent (reference)	48 (82.76%)	21 (56.76%)
Periportal			0.099
Present	9 (15.52%)	9 (24.32%)
Absent (reference)	49 (84.48%)	28 (75.68%)

No ascites, defined as the surgical record clearly indicating no ascites; A small amount of ascites, defined as <1500 mL; Massive ascites, defined as ≥1500 mL (12).